Literature DB >> 2487800

The efficacy of nifedipine and acebutolol in coronary artery disease assessed by radionuclide ventriculography.

R Bauer1, U Busch, L Lutilsky, E van de Flierdt, H R Langhammer, H W Pabst.   

Abstract

The efficacy of a fixed combination of 10 mg nifedipine and 100 mg acebutolol was tested in 21 patients with angiographically proven coronary artery disease (CAD). Ejection fraction (EF), emptying and filling rate (VS and VD), and end-systolic volume (ESV) were assessed by means of radionuclide ventriculography at rest and during exercise prior to as well as 1 hour and 5 hours following oral drug application. Whereas exercise-induced worsening of cardiac function had been documented in all the patients prior to medication, EF and ESV improved significantly after drug administration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487800     DOI: 10.1007/bf00148473

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  7 in total

1.  Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.

Authors:  J Meier
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

2.  [Left ventricular function at rest and during exercise: assessment of ejection fraction, ejection rate and filing rate with radionuclide ventriculography (author's transl)].

Authors:  R Bauer; E Sauer; R Truckenbrodt; H Langhammer; H W Pabst; H Sebening; A Wirtzfeld; H Blömer
Journal:  Herz       Date:  1980-06       Impact factor: 1.443

3.  Treatment of spasm of the coronary artery with nifedipine.

Authors:  M E Bertrand; J M Lablanche; P Y Tilmant
Journal:  Eur Heart J       Date:  1980-12       Impact factor: 29.983

Review 4.  Clinical pharmacology of pindolol.

Authors:  W H Aellig
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

5.  Combined acebutolol/nifedipine therapy in patients with chronic coronary artery disease: additional improvement of ischemia-induced left ventricular dysfunction.

Authors:  M Pfisterer; J Müller-Brand; F Burkart
Journal:  Am J Cardiol       Date:  1982-04-01       Impact factor: 2.778

6.  [Calcium antagonists: effect on peripheral and coronary hemodynamics].

Authors:  R Simon
Journal:  Z Kardiol       Date:  1984

Review 7.  Calcium antagonists. Clinical use in the treatment of angina.

Authors:  P Théroux; Y Taeymans; D D Waters
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.